This was achieved through the direct modification of histone acetylation on the Rb1 promoter, resulting in the silencing of RB1 expression in diverse mouse models like 4T1 mammary carcinoma, Lewis lung carcinoma, and EL-4 thymoma [128]. The gene discussed is RB1; the disease is breast carcinoma.